These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2425160)

  • 1. Bremazocine causes sympatho-inhibition and hypotension in rabbits by activating peripheral kappa-receptors.
    Ensinger H; Hedler L; Szabo B; Starke K
    J Cardiovasc Pharmacol; 1986; 8(3):470-5. PubMed ID: 2425160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid peptides decrease noradrenaline release and blood pressure in the rabbit at peripheral receptors.
    Szabo B; Hedler L; Ensinger H; Starke K
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Jan; 332(1):50-6. PubMed ID: 3005885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral sympatho-inhibitory cardiovascular effects of opioid peptides in anaesthetized rabbits.
    Szabo B; Hedler L; Schurr C; Starke K
    Br J Pharmacol; 1988 Jul; 94(3):781-8. PubMed ID: 2902892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethylketocyclazocine decreases noradrenaline release and blood pressure in the rabbit at a peripheral opioid receptor.
    Ensinger H; Hedler L; Schurr C; Starke K
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Nov; 328(1):20-3. PubMed ID: 6096725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the cannabinoid receptor agonist WIN55212-2 on sympathetic cardiovascular regulation.
    Niederhoffer N; Szabo B
    Br J Pharmacol; 1999 Jan; 126(2):457-66. PubMed ID: 10077239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective inhibition of nociceptive flexion reflex discharge by the kappa agonist bremazocine.
    Banna NR; Al-Amin HA; Jabbur SJ
    Neuropharmacology; 1987; 26(2-3):271-4. PubMed ID: 3035416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diuretic effect of bremazocine, a kappa-opioid with central and peripheral sites of action.
    Salas SP; Roblero J; Ureta H; Huidobro-Toro JP
    J Pharmacol Exp Ther; 1989 Sep; 250(3):992-9. PubMed ID: 2550625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevation of serum corticosterone in rats by bremazocine, a kappa-opioid agonist.
    Fuller RW; Leander JD
    J Pharm Pharmacol; 1984 May; 36(5):345-6. PubMed ID: 6145778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presynaptic inhibitory opioid delta- and kappa-receptors in a branch of the rabbit ileocolic artery.
    Von Kügelgen I; Illes P; Wolf D; Starke K
    Eur J Pharmacol; 1985 Nov; 118(1-2):97-105. PubMed ID: 2867914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discriminative stimulus effects of mu and kappa opioids in the pigeon: analysis of the effects of full and partial mu and kappa agonists.
    Picker MJ; Dykstra LA
    J Pharmacol Exp Ther; 1989 May; 249(2):557-66. PubMed ID: 2566680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bremazocine-induced backwards walking behavior in rats is mediated via opioid kappa receptors.
    Shearman GT; Stenfors C
    Pharmacol Biochem Behav; 1986 Apr; 24(4):861-3. PubMed ID: 3012599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of noradrenaline release in the pithed rabbit: a role for angiotensin II.
    Majewski H; Hedler L; Schurr C; Starke K
    J Cardiovasc Pharmacol; 1984; 6(5):888-96. PubMed ID: 6209496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological profile of various kappa-agonists at kappa-, mu- and delta-opioid receptors mediating presynaptic inhibition of neurotransmitter release in the rat brain.
    Mulder AH; Burger DM; Wardeh G; Hogenboom F; Frankhuyzen AL
    Br J Pharmacol; 1991 Feb; 102(2):518-22. PubMed ID: 1673074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mu-, delta- and kappa-opioid receptor-mediated inhibition of neurotransmitter release and adenylate cyclase activity in rat brain slices: studies with fentanyl isothiocyanate.
    Schoffelmeer AN; Rice KC; Jacobson AE; Van Gelderen JG; Hogenboom F; Heijna MH; Mulder AH
    Eur J Pharmacol; 1988 Sep; 154(2):169-78. PubMed ID: 2906610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discriminative stimulus effects of opioids in pigeons trained to discriminate fentanyl, bremazocine and water: evidence of pharmacological selectivity.
    Picker MJ; Cook CD
    Behav Pharmacol; 1997 Jun; 8(2-3):160-73. PubMed ID: 9833011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of the respiratory depressant and analgesic effects of bremazocine, a kappa-agonist.
    Pazos A; Tristán C; Flórez J
    Life Sci; 1983; 33 Suppl 1():579-81. PubMed ID: 6319913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACTH increases noradrenaline release in pithed rabbits with electrically stimulated sympathetic outflow.
    Szabo B; Hedler L; Lichtwald K; Starke K
    Eur J Pharmacol; 1987 Apr; 136(3):391-9. PubMed ID: 3038571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biphasic alterations of cAMP levels and inhibition of norepinephrine release in iris-ciliary body by bremazocine.
    Russell KR; Potter DE
    J Pharmacol Exp Ther; 2001 Sep; 298(3):941-6. PubMed ID: 11504788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid kappa receptors and the secretion of prolactin (PRL) and growth hormone (GH) in the rat. II. GH and PRL release-inhibiting effects of the opioid kappa receptor agonists bremazocine and U-50,488.
    Krulich L; Koenig JI; Conway S; McCann SM; Mayfield MA
    Neuroendocrinology; 1986; 42(1):82-7. PubMed ID: 3001566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bremazocine: an opiate that induces sedation and analgesia without respiratory depression.
    Freye E; Hartung E; Schenk GK
    Anesth Analg; 1983 May; 62(5):483-8. PubMed ID: 6301311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.